IPX IPERIONX Ltd

Nasdaq


$ 48.54 $ -0.52 (-1.05 %)    

Thursday, 23-Oct-2025 17:44:21 EDT
QQQ $ 613.77 $ 0.00 (0 %)
DIA $ 467.91 $ 0.00 (0 %)
SPY $ 673.84 $ 0.00 (0 %)
TLT $ 91.33 $ 0.00 (0 %)
GLD $ 374.13 $ 0.00 (0 %)
$ 48.95
$ 48.95
$ 45.90 x 5
$ 50.00 x 20
-- - --
$ 12.28 - $ 60.90
101,516
na
nm
$ 1.20
nm
TBD
na
na (nm)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 trumps-rare-earth-push-brings-this-etf-in-focus-amid-china-trade-clash

This rare earth ETF is climbing as U.S.–China tensions reignite the race for critical minerals and a new boom in supply chain i...

 rare-earths-best-kept-secret-stocksmeet-the-hidden-powerhouses

Here's a look at several alternative stocks for investors to consider in the red-hot rare earth sector like ASP Isotopes an...

 roth-capital-reiterates-buy-on-iperionx-raises-price-target-to-74

Roth Capital analyst Joe Reagor reiterates IperionX (NASDAQ:IPX) with a Buy and raises the price target from $64 to $74.

 iperionx-secures-125m-dod-funding-to-accelerate-titanium-production-scale-up-at-virginia-manufacturing-campus

IperionX Limited (IperionX) (NASDAQ:IPX, ASX: IPX)), announces that the U.S. Department of Defense (DoD) has obligated US$12.5 ...

 roth-capital-initiates-coverage-on-iperionx-with-buy-rating-announces-price-target-of-64

Roth Capital analyst Joe Reagor initiates coverage on IperionX (NASDAQ:IPX) with a Buy rating and announces Price Target of ...

 iperionx-rockets-23-after-securing-99m-defense-contract-for-domestic-titanium

IperionX shares jumped after landing a $99 million U.S. Department of Defense contract for domestically produced titanium.

 iperionx-awarded-small-business-innovation-research-phase-iii-contract-by-us-department-of-defense

Low-Cost Domestic Titanium for Defense Applications: Receipt of an SBIR Phase III Indefinite Delivery, Indefinite Quantity (IDI...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION